CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Accumulated Other Comprehensive Income	Stock Subscription Notes Receivable	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024		21,281,247
Beginning balance at Dec. 31, 2024	$ 246,115	$ 213	$ 329,073	$ (60,901)	$ 1,146	$ (30)	$ (23,386)
Beginning balance (in shares) at Dec. 31, 2024				(3,899,109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of new common shares (in shares)		39,347
Issuance of new common shares	970	$ 1	969
Purchase of treasury stock (in shares)				(103,086)
Purchase of treasury stock	(2,575)			$ (2,575)
Issuance of new common shares under stock compensation plan (in shares)		131,588
Issuance of new common shares under stock compensation plan	0	$ 1	(1)
Cancellation of common shares under stock compensation plan (in shares)		(6,998)
Issuance of new common shares under employee stock purchase plan (in shares)		26,023
Issuance of new common shares under employee stock purchase plan	483		483
Stock based compensation	4,557		4,557
Collection on stock subscription notes receivable	11					11
Exercises of conversion feature of convertible note (in shares)		31,007
Exercises of conversion feature of convertible note	433		433
Other comprehensive loss, net of tax	(32)				(32)
Repurchases of common stock (in shares)				(162,929)
Repurchase of common stock	(4,103)			$ (4,103)
Net loss	(1,744)						(1,744)
Ending balance (in shares) at Mar. 31, 2025		21,502,214
Ending balance at Mar. 31, 2025	$ 244,115	$ 215	335,514	$ (67,579)	1,114	(19)	(25,130)
Ending balance (in shares) at Mar. 31, 2025				(4,165,124)
Beginning balance (in shares) at Dec. 31, 2025	17,194,091	21,972,432
Beginning balance at Dec. 31, 2025	$ 261,105	$ 220	355,458	$ (84,931)	895	0	(10,537)
Beginning balance (in shares) at Dec. 31, 2025	(4,778,341)			(4,778,341)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of new common shares (in shares)		7,130
Issuance of new common shares	$ 300		300
Purchase of treasury stock (in shares)				(53,510)
Purchase of treasury stock	(1,801)			$ (1,801)
Issuance of new common shares under stock compensation plan (in shares)		278,880
Issuance of new common shares under stock compensation plan	$ 0	$ 3	(3)
Cancellation of common shares under stock compensation plan (in shares)		(3,627)
Issuance of new common shares under employee stock purchase plan (in shares)	18,558	18,558
Issuance of new common shares under employee stock purchase plan	$ 476		476
Stock based compensation	3,776		3,776
Other comprehensive loss, net of tax	(26)				(26)
Repurchases of common stock (in shares)				(288,098)
Repurchase of common stock	(9,227)			$ (9,227)
Net loss	$ (3,702)						(3,702)
Ending balance (in shares) at Mar. 31, 2026	17,153,424	22,273,373
Ending balance at Mar. 31, 2026	$ 250,901	$ 223	$ 360,007	$ (95,959)	$ 869	$ 0	$ (14,239)
Ending balance (in shares) at Mar. 31, 2026	(5,119,949)			(5,119,949)